Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Originally published as JCO Early Release 10.1200/JCO.2008.16.2768 on June 23 2008

Journal of Clinical Oncology, Vol 26, No 28 (October 1), 2008: pp. 4634-4638
© 2008 American Society of Clinical Oncology.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kyrgidis, A.
Right arrow Articles by Triaridis, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kyrgidis, A.
Right arrow Articles by Triaridis, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Delicious   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Bisphosphonate-Related Osteonecrosis of the Jaws: A Case-Control Study of Risk Factors in Breast Cancer Patients

Athanassios Kyrgidis, Konstantinos Vahtsevanos, Georgios Koloutsos, Charalampos Andreadis, Ioannis Boukovinas, Zisis Teleioudis, Anna Patrikidou, Stefanos Triaridis

From the Department of Oral Maxillofacial Surgery, 3rd Department of Clinical Oncology, and 2nd Department of Clinical Oncology, Theagenio Cancer Hospital; and 1st University Department of Otolaryngology, Aristotle University, AHEPA Hospital, Thessaloniki, Greece

Corresponding author: Kyrgidis Athanassios, MD, 3 Papazoli St, 546 30, Thessaloniki, Greece; e-mail: akyrgidi{at}dent.auth.gr, akyrgidi{at}gmail.com

Purpose Osteonecrosis of the jaws (ONJ) was initially described in 2001 in patients receiving intravenous bisphosphonate (BP) treatment. The objective of the present study was to determine whether routine dental procedures can be considered as possible risk factors for the development of ONJ in breast cancer patients receiving BP.

Patients and Methods Twenty breast cancer patients who developed ONJ receiving BP treatment were included in group A, whereas group B consisted of 40 matched controls (breast cancer patients who did not progress to ONJ receiving BP treatment). Routine dental care, smoking habits, history of tooth extraction, use of dentures, and root canal therapy were recorded.

Results Our results indicate that history of tooth extraction during zoledronic acid treatment (adjusted odds ratio [OR] = 16.4; 95% CI, 3.4 to 79.6) and the use of dentures (adjusted OR = 4.9; 95% CI, 1.2 to 20.1) increase the risk of developing ONJ.

Conclusion The outcome of the present study suggests early referral by oncologists for dental evaluation for every patient to be treated with BP. These results raise the current American Society of Clinical Oncology Level of Evidence linking certain dental procedures with ONJ from V to III. Further studies are needed to assess other possible risk factors and also to highlight the etiopathogenesis mechanism of ONJ.

published online ahead of print at www.jco.org on June 23, 2008.

Authors’ disclosures of potential conflicts of interest and author contributions are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
A. Kyrgidis, E. Verrou, K. Kitikidou, C. G. Andreadis, I. Katodritou, and K. Vahtsevanos
Reply to I. Abraham
J. Clin. Oncol., March 20, 2010; 28(9): e145 - e147.
[Full Text] [PDF]


Home page
JCOHome page
K. Vahtsevanos, A. Kyrgidis, E. Verrou, E. Katodritou, S. Triaridis, C. G. Andreadis, I. Boukovinas, G. E. Koloutsos, Z. Teleioudis, K. Kitikidou, et al.
Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the Jaw
J. Clin. Oncol., November 10, 2009; 27(32): 5356 - 5362.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
P. K. Palaska, V. Cartsos, and A. I. Zavras
Bisphosphonates and Time to Osteonecrosis Development
Oncologist, November 1, 2009; 14(11): 1154 - 1166.
[Abstract] [Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
S. Almazrooa and S.-B. Woo
Authors' response
J Am Dent Assoc, October 1, 2009; 140(10): 1217 - 1218.
[Full Text] [PDF]


Home page
Journal of the American Dental AssociationHome page
A. Kyrgidis and K. Vahtsevanos
OSTEONECROSIS OF THE JAW
J Am Dent Assoc, October 1, 2009; 140(10): 1216 - 1217.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Kyrgidis and C. Andreadis
Clinical Characterization Might Help in Preventing Osteonecrosis of the Jaw
Clin. Cancer Res., December 15, 2008; 14(24): 8321 - 8321.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online